Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

505 amino acid protein, corresponding to amino acids 2-506 of the wild type human histidyl-tRNA synthetase

EU orphan designation number: EU/3/15/1448   
Active ingredient: 505 amino acid protein, corresponding to amino acids 2-506 of the wild type human histidyl-tRNA synthetase
Indication: Treatment of facioscapulohumeral muscular dystrophy
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/268/14 (2015)953 of 12/02/2015
22/05/2017 Change of name and/or address of sponsor